Vortex Biosciences

Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering, and informatics to provide better tools for the isolation and characterization of circulating tumor cells (CTCs). Vortex's first product, the VTX-1 Liquid Biopsy System, can automatically isolate and collect live CTCs directly from whole blood. The mission of Vortex Biosciences is to become an innovative leader in CTC capture technology, providing diagnostic tests to improve treatment decisions and save lives. A paradigm shift is underway in how cancer is diagnosed and treated. The combination of targeted therapies and precise diagnostic methods has ushered in the era of personalized medicine. The capture and enrichment of circulating tumor cells will become a key element in targeted companion diagnostics. We believe that our next-generation CTC capture system will ultimately unlock the full diagnostic potential of CTCs.